Effects of coronary angioplasty on monocyte tissue factor response in patients with stable or unstable angina

B Agraou1, D Corseaux, E P McFadden

  • 1Laboratoire d'Hématologie, Centre Hospitalier Régional Universitaire, Lille, France.

Thrombosis Research
|November 15, 1997
PubMed

Insights

Balloon coronary angioplasty can cause thrombosis and restenosis due to plaque disruption. Leukocyte activation may contribute to these complications and vascular healing after the procedure.

Area of Science:

  • Cardiovascular Medicine
  • Interventional Cardiology
  • Vascular Biology

Background:

  • Balloon coronary angioplasty (BCA) is a revascularization technique that widens narrowed arteries by disrupting atherosclerotic plaque.
  • Complications such as thrombosis (5%) and restenosis (30%) can occur after BCA.
  • These complications are linked to blood exposure to plaque and vascular wall components, activating coagulation and platelets.

Purpose of the Study:

  • To investigate the role of leukocyte activation in vascular healing and complications following coronary angioplasty.

Main Methods:

  • Analysis of leukocyte adhesive receptor expression post-angioplasty.
  • Assessment of coagulation and platelet activation markers.

Main Results:

  • Coronary angioplasty leads to mechanical disruption of atherosclerotic plaque and vascular wall stretching.
  • Increased leukocyte adhesive receptors indicate leukocyte activation following the procedure.
  • Leukocyte activation may be a key factor in vascular healing and contribute to thrombotic/stenotic complications.

Conclusions:

  • Leukocyte activation is a significant process after coronary angioplasty.
  • This activation may play a crucial role in both the vascular healing response and the development of post-angioplasty complications like thrombosis and restenosis.

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...